Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL J OPSAHL

Allopathic & Osteopathic Physicians Family Medicine

NPI
1619953742
CMS profile
254504
Location
WAYNESVILLE, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$644.11

41 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $644.11 41

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL J OPSAHL

NPI 1619953742 · CMS profile ID 254504

Allopathic & Osteopathic Physicians / Family Medicine

WAYNESVILLE, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619953742?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL J OPSAHL, NPI 1619953742, CMS profile ID 254504. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619953742?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PAUL J OPSAHL, NPI 1619953742, CMS profile ID 254504. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619953742?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PAUL J OPSAHL, NPI 1619953742, CMS profile ID 254504, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–41 of 41 matching records. This page contains 41 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1619953742?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

41 matching records · $644.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 41 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–41 of 41.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $13.8711/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393337 CMS
ABBVIE INC. $29.5811/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393331 CMS
Novo Nordisk Inc $14.6611/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188141438 CMS
ABBVIE INC. $21.9510/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393325 CMS
Exact Sciences Corporation $27.7310/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235317319 CMS
Merck Sharp & Dohme LLC $17.3810/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238311034 CMS
ABBVIE INC. $8.3110/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393313 CMS
ABBVIE INC. $4.3510/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393319 CMS
ABBVIE INC. $14.5910/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393308 CMS
ABBVIE INC. $12.1209/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393302 CMS
ABBVIE INC. $18.6609/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393295 CMS
ABBVIE INC. $17.5009/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393289 CMS
ABBVIE INC. $12.1509/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393285 CMS
Lilly USA, LLC $18.7509/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186814799 CMS
ABBVIE INC. $8.1509/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393279 CMS
Novo Nordisk Inc $15.9108/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188152712 CMS
ABBVIE INC. $12.1208/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393272 CMS
Lilly USA, LLC $14.8308/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186793781 CMS
ABBVIE INC. $12.4308/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393267 CMS
ABBVIE INC. $18.5008/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393261 CMS
Merck Sharp & Dohme LLC $17.8807/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238309334 CMS
ABBVIE INC. $11.0807/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393256 CMS
Exact Sciences Corporation $23.5106/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235317315 CMS
ABBVIE INC. $11.2506/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393250 CMS
Otsuka America Pharmaceutical, Inc. $19.8906/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227440192 CMS
ABBVIE INC. $6.4205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393245 CMS
GlaxoSmithKline, LLC. $21.9905/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191221339 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.3605/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225678698 CMS
ABBVIE INC. $10.3505/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393239 CMS
Lilly USA, LLC $19.6205/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186814797 CMS
Exact Sciences Corporation $21.2005/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235317311 CMS
ABBVIE INC. $11.7104/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393233 CMS
Novo Nordisk Inc $13.5204/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188504816 CMS
Merck Sharp & Dohme LLC $16.9104/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238306496 CMS
Lilly USA, LLC $16.8703/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186825296 CMS
GlaxoSmithKline, LLC. $21.3503/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191659230 CMS
E.R. Squibb & Sons, L.L.C. $13.9702/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184859041 CMS
Lilly USA, LLC $16.3902/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186838565 CMS
Otsuka America Pharmaceutical, Inc. $19.1701/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227440189 CMS
Merck Sharp & Dohme LLC $14.2401/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238132975 CMS
ABBVIE INC. $8.8901/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203393227 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $121.84 1
PY2020 $44.25 3
PY2021 $14.98 1
PY2022 $347.79 20
PY2023 $409.84 25
PY2024 $241.66 13
PY2025 $644.11 41

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $192,380.36 5
PY2024 Recipient $26,708.00 1
PY2024 Principal investigator $101,629.80 7
PY2023 Principal investigator $122,224.72 40
PY2022 Principal investigator $55,603.20 363

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

40 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $1,473.75 11/22/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1008397263
Principal investigator 1 Novartis Pharmaceuticals Corporation $6,751.42 11/16/2023 Non-covered Recipient Entity
PROVIDENCE MEDICAL GROUP
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1017226289
Principal investigator 1 Novo Nordisk AS $1,415.47 10/25/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1008397245
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,207.68 10/12/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1017242869
Principal investigator 1 Novo Nordisk AS $5,436.54 09/22/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1008397217
Principal investigator 1 Novo Nordisk AS $850.00 09/22/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1008397231
Principal investigator 1 Novo Nordisk AS $3,575.51 08/21/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768815
Principal investigator 1 Novo Nordisk AS $5,387.85 08/18/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1007267425
Principal investigator 1 Novo Nordisk AS $6.23 08/02/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195843
Principal investigator 1 Novo Nordisk AS $23.06 08/02/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195859
Principal investigator 1 Novartis Pharmaceuticals Corporation $6,500.00 07/31/2023 Non-covered Recipient Entity
PROVIDENCE MEDICAL GROUP
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1017226425
Principal investigator 1 Novo Nordisk AS $6,278.51 07/31/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768803
Principal investigator 1 Novo Nordisk AS $3,162.50 07/28/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1007267415
Principal investigator 1 Novo Nordisk AS $42.75 07/26/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1007267403
Principal investigator 1 Novo Nordisk AS $4,971.91 06/23/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768791
Principal investigator 1 Novo Nordisk AS $550.00 06/23/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1007267391
Principal investigator 1 Novo Nordisk AS $2,593.35 06/23/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361877
Principal investigator 1 Novo Nordisk AS $5,714.57 05/26/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768779
Principal investigator 1 Novo Nordisk AS $10,103.40 05/26/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361859
Principal investigator 1 Novo Nordisk AS $20.10 05/12/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361821
Principal investigator 1 Novo Nordisk AS $6,344.25 04/26/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768767
Principal investigator 1 Novo Nordisk AS $4,358.70 04/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361841
Principal investigator 1 Novo Nordisk AS $23.06 04/13/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768741
Principal investigator 1 Novo Nordisk AS $23.06 04/05/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195909
Principal investigator 1 Novo Nordisk AS $5,352.38 03/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195809
Principal investigator 1 Novo Nordisk AS $1,431.45 03/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361785
Principal investigator 1 Novo Nordisk AS $400.00 03/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009361803
Principal investigator 1 Novo Nordisk AS $23.06 03/02/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1006768753
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,087.30 02/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
A Double Blind Placebo Controlled Multicenter Study to Evaluate the Efficacy and Safety of Multiple Dose Strengths of CIN 107 as Compared to Placebo After 8 Weeks of Treatment in Patients With Uncontrolled Hypertension No dispute reported 06/30/2026 991126131
Principal investigator 1 Novo Nordisk AS $6,395.24 02/24/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1007826339
Principal investigator 1 Novo Nordisk AS $2,908.80 02/22/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009068747
Principal investigator 1 Novo Nordisk AS $6.23 02/16/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195824
Principal investigator 1 Novo Nordisk AS $23.06 02/16/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195875
Principal investigator 1 Novo Nordisk AS $23.06 02/16/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1009195893
Principal investigator 1 Novo Nordisk AS $9,726.43 01/27/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1007826333
Principal investigator 1 Novo Nordisk AS $23.06 01/25/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1007826319
Principal investigator 1 Novo Nordisk AS $6,970.05 01/25/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009068731
Principal investigator 1 Novo Nordisk AS $11.64 01/23/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 1009068711
Principal investigator 1 Novo Nordisk AS $6.23 01/04/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1007826313
Principal investigator 1 Novo Nordisk AS $23.06 01/04/2023 Non-covered Recipient Entity
PROVIDENCE HEALTH PARTNERS CENTER FOR CLINICAL RESEARCH
NN9535-4984 No dispute reported 06/30/2026 1007826325